Wedge Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-274,939
Closed -$46M 635
2019
Q2
$46M Sell
274,939
-185
-0.1% -$25.6K 0.53% 49
2019
Q1
$40.3M Buy
275,124
+52,785
+24% +$7.65M 0.46% 69
2018
Q4
$29.7M Buy
222,339
+35,227
+19% +$5.77M 0.37% 100
2018
Q3
$35.6M Sell
187,112
-1,182
-0.6% -$217K 0.34% 85
2018
Q2
$31.4M Buy
+188,294
New +$30.2M 0.31% 89

Other funds holding AGN

Wedge Capital Management's AGN Position: Q3 2019 in Review

Wedge Capital Management sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 274,939 shares — an estimated $46M sold.

Wedge Capital Management first reported a position in AGN in Q2 2018 and held it in 5 quarters. The position peaked at $46M in Q2 2019. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Wedge Capital Management reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Wedge Capital Management sold 274,939 Allergan plc shares in Q3 2019, an estimated $46M.
  • Wedge Capital Management first reported a position in Allergan plc in Q2 2018 and held it in 5 quarters.
  • Wedge Capital Management's Allergan plc position peaked at $46M in Q2 2019.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Wedge Capital Management's 13F filing for Q3 2019, filed 1 Nov 2019.